Page last updated: 2024-08-22

copper sulfate and 2019 Novel Coronavirus Disease

copper sulfate has been researched along with 2019 Novel Coronavirus Disease in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's3 (100.00)2.80

Authors

AuthorsStudies
Bou, G; Cuenca-Estrella, M; Delgado-Iribarren, A; Domínguez-Fernández, M; García, J; González-Donapetry, P; González-Romo, F; Merino-Amador, P; Oteo-Iglesias, J; Sánchez-Castellano, MÁ; Seoane-Estevez, A1
Han, WGH; Hellwich, M; Hooft, L; Kluytmans, JAJW; Koppelman, M; Lodder, EB; Molenkamp, R; Moons, KGM; Nagel-Imming, CRS; Pas, SD; Schuit, E; Smeets, LC; van de Wijgert, JHHM; van den Bijllaardt, W; van den Hof, S; Veldhuijzen, IK; Venekamp, RP; Vroom, IH; Wijers, CJH; Zwart, VF1
Albert, E; Álvarez, G; Colomina, J; Navarro, D; Poujois, S; Torres, I1

Other Studies

3 other study(ies) available for copper sulfate and 2019 Novel Coronavirus Disease

ArticleYear
Clinitest rapid COVID-19 antigen test for the diagnosis of SARS-CoV-2 infection: A multicenter evaluation study.
    Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2021, Volume: 143

    Topics: Antigens, Viral; Citric Acid; Copper Sulfate; COVID-19; Humans; Prospective Studies; Reproducibility of Results; SARS-CoV-2; Sensitivity and Specificity; Sodium Bicarbonate

2021
Diagnostic accuracy of covid-19 rapid antigen tests with unsupervised self-sampling in people with symptoms in the omicron period: cross sectional study.
    BMJ (Clinical research ed.), 2022, 09-14, Volume: 378

    Topics: Citric Acid; Copper Sulfate; COVID-19; COVID-19 Testing; Cross-Sectional Studies; Humans; Netherlands; Prospective Studies; Sodium Bicarbonate; Specimen Handling

2022
Point-of-care evaluation of a rapid antigen test (CLINITEST
    The Journal of infection, 2021, Volume: 82, Issue:5

    Topics: Citric Acid; Copper Sulfate; COVID-19; Humans; Point-of-Care Systems; SARS-CoV-2; Sensitivity and Specificity; Sodium Bicarbonate

2021